Search by :
|
With the flu season in full swing, Clinical Labs of Hawaii would
like to remind all providers of our current test options.
|
|
|
Effective November 14, 2016, the Cancer Antigen 15-3 assay is
being performed on the Roche COBAS and as a result, the reference
range has been updated.
|
|
|
Unfractionated Heparin Testing is now available on Maui.
|
|
|
Explanation of HMSA's precertification process
|
|
|
On September 1, 2016, Medicare published an updated version of
its statutorily excluded Molecular Diagnostic (MolDx) tests. This
bulletin provides an explanation and instructions on how to access
this list.
|
|
|
Expanded collection sites now available for the H.pylori Breath
Test.
|
|
|
The Film Array Meningitis/Encephalitis Panel is an FDA approved,
comprehensive, multiplex molecular assay which accurately detects
multiple organisms, including viruses, all on a single, minimal
volume CSF specimen.
|
|
|
Beginning October 3, 2016, Kapiolani Medical Center for Women
and Children will offer the Respiratory Panel by PCR on site to
assist healthcare providers with faster diagnoses, improved
antibiotic stewardship and quicker results. This test will continue
to be offered at our reference lab as well.
|
|
|
Heparin Therapeutic Range will be adjusted effective September
26, 2016.
|
|
|
The Cepheid Xpert® MTB/RIF Direct PCR assay rapidly identifies
M. tuberculosis organisms, simultaneously detects
rifampin-resistant MTB, and aids in the decision of whether
continued airborne infection isolation is warranted for patients
with suspected pulmonary tuberculosis.
|
|